Drug ADME

Pathway network for the Drug ADME SuperPath

Sources:
  • Reactome
  • PharmGKB
  • WikiPathways

Pathways in the Drug ADME SuperPath

#NameSourceGenes
1Drug ADMEReactome
2Aspirin ADMEReactome
3Codeine and Morphine Pathway, PharmacokineticsPharmGKB
4Irinotecan Pathway, PharmacodynamicsPharmGKB
5Mycophenolic acid Pathway, Pharmacokinetics/PharmacodynamicsPharmGKB
6Reactome/PharmGKB collaboration: Ribavirin Pathway, PharmacokineticsPharmGKB
7Atorvastatin Pathway, PharmacokineticsPharmGKB
8Codeine and morphine metabolismWikiPathways
9Ribavirin ADMEReactome
10Carvedilol Pathway, PharmacokineticsPharmGKB
11Apatinib Pathway, PharmacokineticsPharmGKB
12Reactome/PharmGKB collaboration: Prednisone and Prednisolone Pathway, PharmacokineticsPharmGKB
13Prednisone ADMEReactome
14Pitavastatin Pathway, PharmacokineticsPharmGKB
15Atorvastatin ADMEReactome
16Abacavir ADMEReactome
17Dolutegravir Pathway, PharmacokineticsPharmGKB
18Hydrocodone Pathway, PharmacokineticsPharmGKB
19Ciprofloxacin ADMEReactome
20Abacavir transmembrane transportReactome
21Abacavir metabolismReactome
22Dexamethasone Pathway, Pharmacokinetics/PharmacodynamicsPharmGKB

Gene overlap in member pathways for Drug ADME SuperPath

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with Drug ADME SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1Gilbert syndromeEnrichmentSLCO1B1, UGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A8, UGT1A916.00
2Bilirubin metabolic disorderEnrichmentUGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A8, UGT1A916.00
3Crigler-najjar syndrome, type iEnrichmentUGT1A1, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A8, UGT1A916.00
4Hyperbilirubinemia, transient familial neonatalEnrichmentUGT1A1, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A8, UGT1A916.00
5Bilirubin, serum level of, quantitative trait locus 1EnrichmentUGT1A1, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A8, UGT1A916.00
6Crigler-najjar syndrome, type iiEnrichmentUGT1A1, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A8, UGT1A916.00
7Hyperbilirubinemia, rotor typeEnrichmentSLCO1B1, SLCO1B35.93
8Apparent mineralocorticoid excessEnrichmentHSD11B23.66
9Vitamin d-dependent rickets, type 3EnrichmentCYP3A43.66
10Phosphoenolpyruvate carboxykinase deficiency, cytosolicEnrichmentPCK13.53
11Severe combined immunodeficiencyEnrichmentADA, PNP3.51
12Uric acid concentration, serum, quantitative trait locus 1EnrichmentABCG23.43
13Hyperthyroxinemia, familial dysalbuminemicEnrichmentALB3.43
14Blood group, junior systemEnrichmentABCG23.43
15Congenital analbuminemiaEnrichmentALB3.43
16AnalbuminemiaEnrichmentALB3.43
17Colchicine resistanceEnrichmentABCB13.43
18Encephalopathy, acute transientEnrichmentABCB13.43
19Inflammatory bowel disease 13EnrichmentABCB13.43
20Cortisone reductase deficiency 2EnrichmentHSD11B13.35
21Cortisone reductase deficiencyEnrichmentHSD11B13.35
22Drug metabolism, poor, cyp2d6-relatedEnrichmentCYP2D63.35
23Spastic paraplegia 45, autosomal recessiveEnrichmentNT5C23.23
24Frontotemporal dementia and/or amyotrophic lateral sclerosis 7EnrichmentPON1, PON33.20
25Corticosteroid-binding globulin deficiencyEnrichmentSERPINA63.13
26Bone mineral density quantitative trait locus 12EnrichmentUGT2B173.13
27Hypermethioninemia due to adenosine kinase deficiencyEnrichmentADK3.09
28Hemolytic disease of the fetusEnrichmentSLC29A13.09
29Purine nucleoside phosphorylase deficiencyEnrichmentPNP3.09
30Phosphoenolpyruvate carboxykinase deficiencyEnrichmentPCK13.05
31Drug metabolism, altered, cyp2c8-relatedEnrichmentCYP2C83.05
32Retinitis pigmentosa 10EnrichmentIMPDH13.02
33Impdh2 enzyme activity, variation inEnrichmentIMPDH23.02
34Drug metabolism, altered, ces1-relatedEnrichmentCES13.02
35Leber congenital amaurosis 11EnrichmentIMPDH13.02
36Butyrylcholinesterase deficiencyEnrichmentBCHE2.99
37Coumarin resistanceEnrichmentCYP2C92.88
38Microvascular complications of diabetes 5EnrichmentPON12.88
39Ehlers-danlos syndrome, arthrochalasia type, 1EnrichmentALB2.83
40Histiocytosis-lymphadenopathy plus syndromeEnrichmentSLC29A32.79
41Inosine triphosphatase deficiencyEnrichmentITPA2.79
42Developmental and epileptic encephalopathy 35EnrichmentITPA2.79
43Mitochondrial dna depletion syndrome 21EnrichmentGUK12.75
44Dubin-johnson syndromeEnrichmentABCC22.70
45Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiencyEnrichmentADA2.61
46DysosteosclerosisEnrichmentSLC29A32.61
47Gtp cyclohydrolase 1-deficient dopa-responsive dystoniaEnrichmentIMPDH22.54
48Adenosine deaminase deficiencyEnrichmentADA2.49
49Drug metabolism, poor, cyp2c19-relatedEnrichmentCYP2C192.49
50Erythrocyte lactate transporter defectEnrichmentSLC16A12.49
51Pseudoxanthoma elasticumEnrichmentABCC22.40
52Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-negativeEnrichmentADA2.39
53Epilepsy, idiopathic generalizedEnrichmentABCB12.39
54Developmental dysplasia of the hip 1EnrichmentAKR1C12.35
55Monocarboxylate transporter 1 deficiencyEnrichmentSLC16A12.19
56Hyperinsulinemic hypoglycemia, familial, 7EnrichmentSLC16A12.19
57Ketoacidosis due to monocarboxylate transporter-1 deficiencyEnrichmentSLC16A12.19
58Tooth agenesis, selective, 1EnrichmentITPA2.14
59Acetylation, slowEnrichmentNAT22.09
60Thiopurines, poor metabolism of, 1EnrichmentTPMT2.09
61GlutathionuriaEnrichmentGGT12.09
62Deafness, autosomal dominant 77EnrichmentABCC12.09
63Thiopurines, poor metabolism of, 2EnrichmentNUDT152.09
64Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndromEnrichmentRAC12.09
65Omenn syndromeEnrichmentADA2.09
66Hypertension, essentialEnrichmentCYP3A51.86
67Xanthinuria, type iEnrichmentXDH1.80
68Intellectual developmental disorder, autosomal dominant 48EnrichmentRAC11.80
69Kala-azar 2EnrichmentGSTP11.80
70Tooth agenesisEnrichmentITPA1.75
71Developmental and epileptic encephalopathy 1EnrichmentITPA1.70
72Lesch-nyhan syndromeEnrichmentHPRT11.62
73Hyperuricemia, hprt-relatedEnrichmentHPRT11.62
74Xanthinuria, type iiEnrichmentXDH1.62
75Developmental and epileptic encephalopathyEnrichmentITPA1.54
76Aminoacylase 1 deficiencyEnrichmentACY11.50
77DystoniaEnrichmentIMPDH21.48
78Neurodevelopmental disorder with dysmorphic facies and distal limb anomaliesEnrichmentRAC11.15
79Leber plus diseaseEnrichmentIMPDH11.06
80Retinitis pigmentosaEnrichmentIMPDH10.73
81Hereditary retinal dystrophyEnrichmentIMPDH10.61
82Fundus dystrophyEnrichmentIMPDH10.61
83Rare autosomal dominant non-syndromic sensorineural deafness type dfnaEnrichmentABCC10.46

Loading...
Loading...
Loading...